Bioqual, Inc. (BIOQ)

OTCMKTS · Delayed Price · Currency is USD
37.51
-0.19 (-0.50%)
At close: Feb 6, 2026
Market Cap33.55M -18.5%
Revenue (ttm)46.54M -7.5%
Net Income453.26K
EPS0.51
Shares Out894.42K
PE Ratio74.02
Forward PEn/a
Dividend0.50 (1.33%)
Ex-Dividend DateOct 7, 2024
Volume233
Average Volume750
Open37.51
Previous Close37.70
Day's Range37.51 - 37.51
52-Week Range33.00 - 57.50
Beta-0.07
RSI21.71
Earnings DateApr 16, 2026

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and ... [Read more]

Sector Healthcare
Founded 1981
Employees 113
Stock Exchange OTCMKTS
Ticker Symbol BIOQ
Full Company Profile

Financial Performance

Financial Statements